Literature DB >> 17541956

Estrogen-TGFbeta cross-talk in bone and other cell types: role of TIEG, Runx2, and other transcription factors.

J R Hawse1, M Subramaniam, J N Ingle, M J Oursler, N M Rajamannan, T C Spelsberg.   

Abstract

It is well established that E(2) and TGFbeta have major biological effects in multiple tissues, including bone. The signaling pathways through which these two factors elicit their effects are well documented. However, the interaction between these two pathways and the potential consequences of cross-talk between E(2) and TGFbeta continue to be elucidated. In this prospectus, we present known and potential roles of TIEG, Runx2, and other transcription factors as important mediators of signaling between these two pathways. (c) 2007 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 17541956      PMCID: PMC3372922          DOI: 10.1002/jcb.21425

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  79 in total

Review 1.  Molecular and cellular mechanisms of estrogen action on the skeleton.

Authors:  D J Rickard; M Subramaniam; T C Spelsberg
Journal:  J Cell Biochem       Date:  1999       Impact factor: 4.429

Review 2.  Regulation of transforming growth factor beta by sex steroids.

Authors:  S Hering; D Sürig; D Freystadt; H Schatz; A Pfeiffer
Journal:  Horm Metab Res       Date:  1995-08       Impact factor: 2.936

3.  Mechanisms by which high-dose estrogen therapy produces anabolic skeletal effects in postmenopausal women: role of locally produced growth factors.

Authors:  S Bord; S Beavan; D Ireland; A Horner; J E Compston
Journal:  Bone       Date:  2001-09       Impact factor: 4.398

4.  Human giant cell tumors of the bone (osteoclastomas) are estrogen target cells.

Authors:  M J Oursler; L Pederson; L Fitzpatrick; B L Riggs; T Spelsberg
Journal:  Proc Natl Acad Sci U S A       Date:  1994-06-07       Impact factor: 11.205

5.  Thrombospondin co-localises with TGF beta and IGF-I in the extracellular matrix of human osteoblast-like cells and is modulated by 17 beta estradiol.

Authors:  M Slater; J Patava; R S Mason
Journal:  Experientia       Date:  1995-03-15

6.  Modulation of transforming growth factor-beta production in normal human osteoblast-like cells by 17 beta-estradiol and parathyroid hormone.

Authors:  M J Oursler; C Cortese; P Keeting; M A Anderson; S K Bonde; B L Riggs; T C Spelsberg
Journal:  Endocrinology       Date:  1991-12       Impact factor: 4.736

7.  Avian osteoclasts as estrogen target cells.

Authors:  M J Oursler; P Osdoby; J Pyfferoen; B L Riggs; T C Spelsberg
Journal:  Proc Natl Acad Sci U S A       Date:  1991-08-01       Impact factor: 11.205

8.  Purification and characterization of two cartilage-inducing factors from bovine demineralized bone.

Authors:  S M Seyedin; T C Thomas; A Y Thompson; D M Rosen; K A Piez
Journal:  Proc Natl Acad Sci U S A       Date:  1985-04       Impact factor: 11.205

9.  Ovariectomy selectively reduces the concentration of transforming growth factor beta in rat bone: implications for estrogen deficiency-associated bone loss.

Authors:  R D Finkelman; N H Bell; D D Strong; L M Demers; D J Baylink
Journal:  Proc Natl Acad Sci U S A       Date:  1992-12-15       Impact factor: 11.205

10.  Transforming growth factor-beta 3 is required for secondary palate fusion.

Authors:  G Proetzel; S A Pawlowski; M V Wiles; M Yin; G P Boivin; P N Howles; J Ding; M W Ferguson; T Doetschman
Journal:  Nat Genet       Date:  1995-12       Impact factor: 38.330

View more
  19 in total

1.  TGF-β mediates suppression of adipogenesis by estradiol through connective tissue growth factor induction.

Authors:  Ashok Kumar; Ming Ruan; Kari Clifton; Farhan Syed; Sundeep Khosla; Merry Jo Oursler
Journal:  Endocrinology       Date:  2011-11-08       Impact factor: 4.736

2.  TIEG and estrogen modulate SOST expression in the murine skeleton.

Authors:  Malayannan Subramaniam; Kevin S Pitel; Elizabeth S Bruinsma; David G Monroe; John R Hawse
Journal:  J Cell Physiol       Date:  2017-11-24       Impact factor: 6.384

3.  Insulin receptor substrate 2 plays important roles in 17beta-estradiol-induced bone formation.

Authors:  Y-H Bu; D Peng; H-D Zhou; Q-X Huang; W Liu; X-B Luo; L-L Tang; A-G Tang
Journal:  J Endocrinol Invest       Date:  2009-05-26       Impact factor: 4.256

4.  Integrated pharmacometrics and systems pharmacology model-based analyses to guide GnRH receptor modulator development for management of endometriosis.

Authors:  M M Riggs; M Bennetts; P H van der Graaf; S W Martin
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2012-10-17

5.  TGFβ Regulation of Perilacunar/Canalicular Remodeling Is Sexually Dimorphic.

Authors:  Neha S Dole; Cristal S Yee; Courtney M Mazur; Claire Acevedo; Tamara Alliston
Journal:  J Bone Miner Res       Date:  2020-05-13       Impact factor: 6.390

Review 6.  Osteoarthritis associated with estrogen deficiency.

Authors:  Jorge A Roman-Blas; Santos Castañeda; Raquel Largo; Gabriel Herrero-Beaumont
Journal:  Arthritis Res Ther       Date:  2009-09-21       Impact factor: 5.156

7.  Ten-Year Simulation of the Effects of Denosumab on Bone Remodeling in Human Biopsies.

Authors:  Duncan C Tourolle; David W Dempster; Charles Ledoux; Daniele Boaretti; Mauricio Aguilera; Najma Saleem; Ralph Müller
Journal:  JBMR Plus       Date:  2021-04-05

8.  Growth hormone protects against ovariectomy-induced bone loss in states of low circulating insulin-like growth factor (IGF-1).

Authors:  J Christopher Fritton; Kelly B Emerton; Hui Sun; Yuki Kawashima; Wilson Mejia; Yingjie Wu; Clifford J Rosen; David Panus; Mary Bouxsein; Robert J Majeska; Mitchell B Schaffler; Shoshana Yakar
Journal:  J Bone Miner Res       Date:  2010-02       Impact factor: 6.741

9.  Chitosan nanofiber scaffold improves bone healing via stimulating trabecular bone production due to upregulation of the Runx2/osteocalcin/alkaline phosphatase signaling pathway.

Authors:  Ming-Hua Ho; Chih-Jung Yao; Mei-Hsiu Liao; Pei-I Lin; Shing-Hwa Liu; Ruei-Ming Chen
Journal:  Int J Nanomedicine       Date:  2015-09-22

10.  Bone Morphogenetic Protein-2 Desensitizes MC3T3-E1 Osteoblastic Cells to Estrogen Through Transcriptional Downregulation of Estrogen Receptor 1.

Authors:  Osamu Ishibashi
Journal:  J Bone Metab       Date:  2013-11-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.